Miwa H, Mizuno Y
Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
No To Shinkei. 1996 Feb;48(2):149-54.
We report six patients with dystonia-parkinsonism syndrome having a common characteristic clinical course of dystonia with subsequent development of levodopa-responsive parkinsonism. Various types of dystonic symptoms were observed such as hemidystonia, torticollis, axial dystonia, focal dystonia, or cranial dystonia (Meige's syndrome). Intervals between the onset of dystonia and that of parkinsonism varied from one year to about 20 years or the more. Levodopa and a dopamine against had inconstant effects on their dystonic symptoms except for the torticollis of the patients; on the other hand, parkinsonism were well relieved by levodopa in all of them. Dystonic symptoms showed heterogeneous drug effects. Carbamazepine had a beneficial effect on hemidystonia in a patient with hemidystonia-parkinsonism. In a patient with an unilateral hand cramp-ipsilateral parkinsonism, the focal dystonic symptom was evoked by cigarette smoking. Meige's syndrome became worse by the administration of levodopa. In contrast, in a patient with younger onset toriticollis-parkinsonism, both symptoms were fully relieved by levodopa. From the clinical and pharmacological points of views, this type of dystonia-parkinsonism, characterized by dystonia with later development of dopa-responsive parkinsonism, is a syndrome showing heterogeneous dopa-response, and it remains uncertain, at the present, that whether or not patients reported here share the same clinicopathological background such as striatal dopamine deficiency.
我们报告了6例患有肌张力障碍-帕金森综合征的患者,他们具有共同的特征性临床病程,即先出现肌张力障碍,随后发展为对左旋多巴有反应的帕金森病。观察到了各种类型的肌张力障碍症状,如偏侧肌张力障碍、斜颈、轴性肌张力障碍、局灶性肌张力障碍或颅肌张力障碍(梅杰综合征)。肌张力障碍发作与帕金森病发作之间的间隔从1年到约20年或更长时间不等。左旋多巴和多巴胺拮抗剂对患者的肌张力障碍症状(除患者的斜颈外)效果不一;另一方面,所有患者的帕金森病都能被左旋多巴很好地缓解。肌张力障碍症状显示出不同的药物效应。卡马西平对1例患有偏侧肌张力障碍-帕金森病的患者的偏侧肌张力障碍有有益作用。在1例患有单侧手部痉挛-同侧帕金森病的患者中,吸烟可诱发局灶性肌张力障碍症状。左旋多巴给药后梅杰综合征加重。相反,在1例发病较早的斜颈-帕金森病患者中,两种症状都被左旋多巴完全缓解。从临床和药理学角度来看,这种以肌张力障碍伴随后发展为对多巴有反应的帕金森病为特征的肌张力障碍-帕金森综合征是一种多巴反应各异的综合征,目前尚不确定这里报告的患者是否具有相同的临床病理背景,如纹状体多巴胺缺乏。